Table 2. .
SNP | Nucleotide Position |
SNP Name | Genotype | GRRa (95% CI) | Z | Pb |
16 | 411873 | IGR2008a_1 | C/C | 2.15 (1.26–3.67) | 2.82 | .0047 |
26* | 435282 | IGR2055a_1 | G/G | 2.14 (1.30–3.53) | 3.00 | .0027 |
27* | 437682 | IGR2060a_1 | C/C | 2.19 (1.31–3.65) | 2.99 | .0028 |
28* | 438883 | IGR2063b_1 | G/G | 2.21 (1.34–3.64) | 3.11 | .0019 |
34* | 455246 | IGR2096a_1 | C/C | .35 (.17–.72) | −2.88 | .0039 |
39* | 506266 | IGR2198a_1 | G/G | 2.32 (1.44–3.75) | 3.46 | .00055 |
49 | 522600 | IGR2230a_1 | T/T | 2.40 (1.35–4.28) | 2.96 | .003 |
56 | 571022 | IGR3005a_2 | G/G | 1.99 (1.25–3.15) | 2.92 | .0035 |
57 | 576586 | IGR3016a_1 | G/G | 2.36 (1.36–4.09) | 3.04 | .0023 |
65* | 582948 | IGR3029a_2 | G/G | 2.25 (1.40–3.61) | 3.37 | .00076 |
67* | 587836 | IGR3039a_1 | A/A | 1.92 (1.21–3.06) | 2.76 | .0058 |
74* | 608759 | IGR3081a_1 | T/T | .36 (.17–.74) | −2.79 | .0053 |
78* | 616241 | IGR3096a_1 | T/T | .34 (.16–.73) | −2.80 | .0052 |
86 | 649061 | IGR3162a_1 | G/G | .21 (.06–.72) | −2.48 | .013 |
90 | 662819 | IGR3189a_2 | T/T | .29 (.12–.72) | −2.68 | .0073 |
91* | 676688 | IGRX100a_1 | A/A | 1.97 (1.17–3.32) | 2.55 | .011 |
92 | 683387 | IGR3230a_1 | T/T | .37 (.17–.78) | −2.60 | .0094 |
93* | 686249 | IGR3236a_1 | G/G | .39 (.21–.75) | −2.83 | .0046 |
102* | 877809 | GENS020ex3_1 | C/C | .42 (.24–.73) | −3.05 | .0023 |
Note.— SNPs identified by Rioux et al.17 are shown in bold, and SNPs identified by the KWII are identified by an asterisk (*).
Genotype relative risk, in which the reference genotype is the heterozygote.
All P values are significant after correction for multiple testing with use of the method of Benjamini and Hochberg.32